InVivoMAb anti-mouse CD22

Säwén P, Lang S, Mandal P, et al. Mitotic History Reveals Distinct Stem Cell Populations and Their Contributions to Hematopoiesis. Cell Rep. 2016,14(12):2809-18. doi: 10.1016/j.celrep.2016.02.073

Müller J, Obermeier I, Wöhner M, et al. CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling. Proc Natl Acad Sci U S A. 2013,110(30):12402-7. doi: 10.1073/pnas.1304888110

Wöhner M, Born S, Nitschke L. Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model. Eur J Immunol. 2012,42(11):3009-18. doi: 10.1002/eji.201242629

Efanov A, Zanesi N, Nazaryan N, et al. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. Leukemia. 2010,24(5):970-5. doi: 10.1038/leu.2010.46

Duong BH, Tian H, Ota T, et al. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med. 2010,207(1):173-87. doi: 10.1084/jem.20091873

Gross AJ, Lyandres JR, Panigrahi AK, et al. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J Immunol. 2009,182(9):5382-92. doi: 10.4049/jimmunol.0803941